{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:19:05Z","timestamp":1776158345863,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tins.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T20:15:52Z","timestamp":1753474552000},"page":"655-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Shingles vaccination and neuroimmune vulnerability"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-3070","authenticated-orcid":false,"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben J.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2025.07.003_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2025.07.003_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2025.07.003_bb0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.07.003_bb0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-025-08800-x","article-title":"A natural experiment on the effect of herpes zoster vaccination on dementia","volume":"641","author":"Eyting","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.07.003_bb0025","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2025.07.003_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0092-8674(89)90177-3","article-title":"Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein","volume":"57","author":"Weidemann","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.07.003_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer's disease","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tins.2025.07.003_bb0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2217\/fmb.12.10","article-title":"Could antivirals be used to treat Alzheimer's disease?","volume":"7","author":"Itzhaki","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.tins.2025.07.003_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnagi.2014.00202","article-title":"Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2025.07.003_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2025.07.003_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2449","article-title":"Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques","volume":"217","author":"Wozniak","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.tins.2025.07.003_bb0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jalz.2014.04.522","article-title":"Reactivated herpes simplex infection increases the risk of Alzheimer's disease","volume":"11","author":"Lovheim","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.07.003_bb0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jalz.2014.07.157","article-title":"Herpes simplex infection and the risk of Alzheimer's disease: a nested case\u2013control study","volume":"11","author":"Lovheim","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.07.003_bb0070","article-title":"Association between herpes simplex virus type 1 and the risk of Alzheimer's disease: a retrospective case\u2013control study","volume":"15","author":"Liu","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.tins.2025.07.003_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115109","article-title":"Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer's disease","volume":"44","author":"Hyde","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.07.003_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer's disease-associated beta-amyloid is rapidly seeded by Herpesviridae to protect against brain infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.07.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032112","article-title":"Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial","volume":"10","author":"Devanand","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.tins.2025.07.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112411","article-title":"Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD","volume":"190","author":"Ukraintseva","year":"2024","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.tins.2025.07.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tins.2025.07.003_bb0100","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JVI.02745-06","article-title":"Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia","volume":"81","author":"Cohrs","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.tins.2025.07.003_bb0105","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","article-title":"The recombinant shingles vaccine is associated with lower risk of dementia","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.07.003_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3415","article-title":"Herpes zoster vaccination and the risk of dementia: a systematic review and meta-analysis","volume":"14","author":"Shah","year":"2024","journal-title":"Brain Behav."},{"key":"10.1016\/j.tins.2025.07.003_bb0115","article-title":"Adult vaccination as a protective factor for dementia: a meta-analysis and systematic review of population-based observational studies","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2025.07.003_bb0120","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 Years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2025.07.003_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.tins.2025.07.003_bb0130","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/cid\/ciab629","article-title":"Zoster-049 Study: the adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal Phase 3 clinical trials ZOE-50 and ZOE-70","volume":"74","author":"Boutry","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tins.2025.07.003_bb0135","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1172\/JCI121484","article-title":"Th1 memory differentiates recombinant from live herpes zoster vaccines","volume":"128","author":"Levin","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2025.07.003_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNgamma response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tins.2025.07.003_bb0145","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","author":"Garcon","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tins.2025.07.003_bb0150","article-title":"Recombinant zoster vaccine and reduced risk of dementia: matched-cohort study using large-scale electronic health records and machine learning methodology","volume":"20","author":"Schwab","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.07.003_bb0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3233\/JAD-221231","article-title":"The impact of routine vaccinations on Alzheimer's disease risk in persons 65 years and older: a claims-based cohort study using propensity score matching","volume":"95","author":"Harris","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2025.07.003_bb0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tins.2025.07.003_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tins.2025.07.003_bb0170","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/vaccines9050491","article-title":"Bladder cancer immunotherapy by BCG is associated with a significantly reduced risk of Alzheimer's disease and Parkinson's disease","volume":"9","author":"Klinger","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tins.2025.07.003_bb0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3233\/JAD-230088","article-title":"Vaccination against pneumonia may provide genotype-specific protection against Alzheimer's disease","volume":"96","author":"Ukraintseva","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2025.07.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2216625","article-title":"Do vaccinations influence the development of Alzheimer disease?","volume":"19","author":"Bukhbinder","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.tins.2025.07.003_bb0185","article-title":"Reduced dementia incidence after varicella zoster vaccination in Wales 2013\u20132020","volume":"8","author":"Schnier","year":"2022","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.tins.2025.07.003_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257405","article-title":"Impact of herpes zoster vaccination on incident dementia: a retrospective study in two patient cohorts","volume":"16","author":"Scherrer","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2025.07.003_bb0195","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-9-106","article-title":"Tumor necrosis factor-alpha synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease","volume":"9","author":"Tweedie","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2025.07.003_bb0200","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1471-4159.2012.07846.x","article-title":"3,6'-Dithiothalidomide, a new TNF-alpha synthesis inhibitor, attenuates the effect of Abeta1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit","volume":"122","author":"Russo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2025.07.003_bb0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1567205014666170117141330","article-title":"Poor safety and tolerability hamper reaching a potentially therapeutic dose in the use of thalidomide for Alzheimer's disease: results from a double-blind, placebo-controlled trial","volume":"14","author":"Decourt","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tins.2025.07.003_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2017.02.010","article-title":"Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice","volume":"102","author":"MacPherson","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2025.07.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039027","article-title":"A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias","volume":"103","author":"Haroon","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tins.2025.07.003_bb0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/nmt-2021-0022","article-title":"NM101 Phase III study of NE3107 in Alzheimer's disease: rationale, design and therapeutic modulation of neuroinflammation and insulin resistance","volume":"11","author":"Reading","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.tins.2025.07.003_bb0225","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/vetsci10070438","article-title":"Off-label use of crisdesalazine (GedaCure) in meningoencephalitis in two dogs","volume":"10","author":"Lee","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.tins.2025.07.003_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-024-00920-w","article-title":"Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system","volume":"26","author":"Park","year":"2025","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tins.2025.07.003_bb0235","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/ADR-230181","article-title":"Clinical evidence for GLP-1 receptor agonists in Alzheimer's Disease: a systematic review","volume":"8","author":"Liang","year":"2024","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.tins.2025.07.003_bb0240","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","article-title":"Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial","volume":"29","author":"Gonzales","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.07.003_bb0245","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00401-016-1596-3","article-title":"Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's disease","volume":"132","author":"Gu","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.07.003_bb0250","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2009-11-251744","article-title":"The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of nonopsonized particles and bacteria by a pathway attenuated by extracellular ATP","volume":"115","author":"Gu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tins.2025.07.003_bb0255","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.1101178","article-title":"P2X(7) is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP","volume":"187","author":"Gu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.tins.2025.07.003_bb0260","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.cell.2019.05.056","article-title":"LC3-associated endocytosis facilitates beta-amyloid clearance and mitigates neurodegeneration in murine Alzheimer's disease","volume":"178","author":"Heckmann","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.07.003_bb0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","article-title":"New role of P2X7 receptor in an Alzheimer's disease mouse model","volume":"24","author":"Martin","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2025.07.003_bb0270","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1091\/mbc.e04-11-1025","article-title":"Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth","volume":"16","author":"Adinolfi","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.tins.2025.07.003_bb0275","article-title":"Mitochondrial P2X7 receptor localization modulates energy metabolism enhancing physical performance","volume":"2","author":"Sarti","year":"2021","journal-title":"Function (Oxf)"},{"key":"10.1016\/j.tins.2025.07.003_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.tins.2025.07.003_bb0285","doi-asserted-by":"crossref","first-page":"31287","DOI":"10.1074\/jbc.M313902200","article-title":"An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor","volume":"279","author":"Gu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.07.003_bb0290","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1093\/hmg\/ddv278","article-title":"A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis","volume":"24","author":"Gu","year":"2015","journal-title":"Hum. Mol. Genet."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223625001456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223625001456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:56:58Z","timestamp":1757458618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223625001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0166223625001456"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2025.07.003","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shingles vaccination and neuroimmune vulnerability","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}